Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

Affiliations

• ¹ Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
• ² Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ³ University Hospital of Salamanca/IBSAL/Cancer Research Center - IBMCC (USAL-CSIC), Salamanca, Spain.
• ⁴ Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
• ⁵ Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.
• ⁶ Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
• ⁷ Janssen Research & Development, LLC, Spring House, PA, USA.
• ⁸ Janssen Research & Development, Beerse, Belgium.
• ⁹ Janssen Research & Development, LLC, Leiden, The Netherlands.
• ¹⁰ Janssen Research & Development, LLC, Toronto, Ontario, Canada.
• ¹¹ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹² Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.